Upstate Group upstategroup.com


Public lists: Pharma Startups (6570)

A company that is doing lead inspection and risk assessments in the Tri-State area. The testing is being performed on residential and commercial properties along with all steel structures including, water tanks, towers and bridges. We will test for lead in paint, soil, dust, drinking water.

A company that is doing lead inspection and risk assessments in the Tri-State area. The testing is being performed on residential and commercial properties along with all steel structures including, water tanks, towers and bridges. We will test for l...Show all

Company (Acquired)

Phone: 434-975-4300

Fax: 607-798-7102

706 Forest Street
Suite 1
Charlottesville, 22903
Virginia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Upstate Group $17.1M Oct 5, 2004
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Upstate Group Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

MAP Pharmaceuticals

Mountain View, California, United States
AcquiredMAP Pharmaceuticals is a drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals' goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects. Development programs in neurolog...Show allLogin to see details

Inflabloc Pharmaceuticals

Salt Lake City, Utah, United States
Alive / ActiveInflabloc Pharmaceuticals, Inc. is engaged in the research and development of pharmaceutical treatments for inflammatory disorders. Inflabloc's current product development is based on its discoveries of strong anti-inflammatory properties of dehydroepiandrosterone (DHEA), a steroid that is produced in the adrenal gland. The company's lead product line is a DHEA combination treatment. The company has 4 products in development. IP-1001 is slated to enter Phase 2 clinical trials in Crohn's disease ...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)